Your email has been successfully added to our mailing list.

×
0.049792531120332 0.049792531120332 0.049792531120332 0.049792531120332 0.049792531120332 0.049792531120332 0.049792531120332 0.049792531120332
Stock impact report

Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Vaccinex, Inc. (VCNX) 
Company Research Source: GlobeNewswire
Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected by the end of 2019 Updated interim data from the CLASSICAL-Lung study at the Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting Raised $13.8 million from a private placement in July 2019 with new and existing shareholders ROCHESTER, N.Y., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and Huntington’s disease, today announced financial results for the third quarter ended September 30, 2019 and provided a corporate update. Third Quarter and Recent Accomplishments: In July 2019, entered into a $13.8 million stock purchase agreement with a syndicate including existing significant shareholders FCMI Parent Co. and Vaccinex (Rochester), L.L.C. and a major (5%) new investorIn August 2019, announced completion Show less Read more
Impact Snapshot
Event Time:
VCNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VCNX alerts
Opt-in for
VCNX alerts

from News Quantified
Opt-in for
VCNX alerts

from News Quantified